Presentation Influence of Smoking on the Antiplatelet Effect of Clopidogrel Differs by Dose: GRAVITAS Presenter: Grant Reed February 28, 2016
Presentation PARADOX: Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Clopidogrel and Prasugrel Presenter: Paul A. Gurbel May 03, 2013
Presentation Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms, Noncompliance, Diet, Smoking, Co-medications, and Preexistent Variability in Platelet Func Presenter: Andrew L. Frelinger January 15, 2013
Presentation TCT 2012 TCT-54. The Influence of Smoking Status on the Pharmacodynamics of Prasugrel and Clopidogrel: The PARADOX Study Presenter: Paul Gurbel October 23, 2012
Presentation Prior Smoking Status, Clinical Outcomes, and the Comparison of Ticagrelor with Clopidogrel in ACS Presenter: Jan H. Cornel August 02, 2012
Presentation Cigarette Smoking Associated with a Dose-Response Effect in Clopidogrel-Treated Patients with Diabetes Mellitus and CAD Presenter: M. Ueno March 19, 2012